Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: labetalol.
D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy; D004983:Ethanolamines / Q000494:pharmacology*; D006333:Heart Failure / Q000188:drug therapy; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007700:Kinetics; D007741:Labetalol / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use
D004983:Ethanolamines; D007741:Labetalol